Enlitic Stock

enlitic.comHealthcare / Other HealthcareFounded: 2014Funding to Date: $55MM

Enlitic uses AI and deep learning to help Radiologists identify diseases and medical issues (e.g cancers and tumors) more accurately and earlier. Founded in 2014 by Jeremy Howard and Kevin Lyman, Enlitic is headquartered in San Francisco, California. Enlitic deepens medical learning that leverages proprietary algorithms to accurately improve healthcare diagnosis.

Register To Buy and Sell Shares

For more details on financing and valuation for Enlitic, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Enlitic’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Enlitic.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Enlitic investors also invested in these private companies

Thorney Investment
The Jagen Group
Regal Funds Management
Capitol Health Ltd


Management Team

Michael Sistenich
Chief Executive Officer
John Marshall
Chief Operating Officer
Darren Scotti
Chief Financial Officer
Dan Kozimor
Chief Technology Officer
Thea Moeller
Chief of Staff
Ron Wider
Senior Vice President of Strategy

Board Members

Ben Van Roo
Amplify Partners
Lawrence B. Gozlan
Jagen Pty Ltd
Michael Sistenich
Aurenda Partners

Enlitic’s stock FAQs


Can you buy Enlitic’s stock?

Enlitic is not publicly traded on NYSE or NASDAQ in the U.S. To buy Enlitic’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Enlitic’s stock?

Yes, you can sell stock of a private company like Enlitic. Forge can help you sell your Enlitic stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Enlitic’s stock price?

Enlitic is a privately held company and therefore does not have a public stock price. However, you may access Enlitic’s private market stock price with Forge Data.

What is Enlitic’s stock ticker symbol?

Enlitic does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

AI healthcare tech company Enlitic eyes $300m ASX listing

Enlitic, a Silicon Valley-based healthcare AI firm, is preparing for an ASX listing with a market capitalisation of around $300m. The company, which uses AI to build data management applications for healthcare professionals, is expected to raise about $40m from the float. Enlitic has previously received investment from Regal Funds Management and Thorney companies.
Updated on: Jun 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.